Madrigal Pharmaceuticals Executive and Leadership Team

William Sibold, the Chief Executive Officer at Madrigal Pharmaceuticals, directs the overall corporate strategy and operational execution. Sibold guides the company's focus on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, ensuring alignment with the mission to advance patient care. This leadership involves overseeing the progression of key pipeline assets, including MGL-3196, through critical clinical trial phases. Sibold's strategic direction ensures that resources are allocated effectively to achieve milestones in non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia treatment development. The Chief Executive Officer's role encompasses fostering a culture of innovation and accountability across all departments, driving the company toward its long-term objectives and market impact. William Sibold's executive oversight is crucial for navigating the complex biopharmaceutical landscape and securing the company's future growth and therapeutic contributions.

Clint Wallace, the Executive Vice President & Chief Human Resources Officer at Madrigal Pharmaceuticals, architects the global human capital strategy. Wallace oversees all aspects of talent management, organizational development, and employee engagement, ensuring a high-performing workforce aligned with the company's mission. This executive leadership role involves cultivating a robust corporate culture that supports scientific innovation and the rigorous demands of clinical-stage biopharmaceutical development. Wallace directs initiatives focused on attracting, retaining, and developing top talent essential for advancing therapeutic candidates for cardiovascular, metabolic, and liver diseases. The Chief Human Resources Officer's responsibilities extend to compensation, benefits, and ensuring compliance with labor regulations across all operational geographies. By fostering a supportive and dynamic work environment, Clint Wallace drives employee productivity and commitment, directly contributing to the successful progression of MGL-3196 and other pipeline assets.

Ronald Filippo, the Executive Vice President & Chief Information Officer at Madrigal Pharmaceuticals, spearheads the company's technology vision and digital transformation. Filippo directs the development and implementation of robust IT infrastructure and systems essential for supporting complex biopharmaceutical operations, including clinical trials and data management. This executive leadership ensures the secure and efficient handling of sensitive research and patient data, critical for the advancement of therapeutic candidates like MGL-3196. The Chief Information Officer's purview includes cybersecurity, enterprise resource planning, and leveraging data analytics to drive strategic decision-making across the organization. Ronald Filippo oversees the integration of innovative technologies that enhance operational efficiency and accelerate the company's progress in treating cardiovascular, metabolic, and liver diseases. Filippo's strategic technology leadership is fundamental to Madrigal Pharmaceuticals' ability to scale operations and achieve its development goals.

Joanne Jones, the Senior Executive Assistant To the Chief Human Resources Officer and CITO at Madrigal Pharmaceuticals, provides critical administrative and operational support to key executive functions. Jones manages complex scheduling, coordinates high-level meetings, and facilitates communication between the Chief Human Resources Officer, the Chief Information Officer, and their respective teams. This role is vital for ensuring the seamless operation of human resources and information technology departments, which are fundamental to Madrigal Pharmaceuticals' overall success. Joanne Jones handles confidential information with discretion and supports the execution of strategic initiatives related to talent management and technology infrastructure. By optimizing executive workflows and managing essential administrative tasks, Jones contributes directly to the efficiency and effectiveness of these critical leadership roles, thereby supporting the company's mission to develop novel therapeutics for cardiovascular, metabolic, and liver diseases.

Shannon Kelley, the Executive Vice President & Chief Legal Officer at Madrigal Pharmaceuticals, provides comprehensive legal counsel and oversees all legal affairs for the organization. Kelley directs the company's legal strategy, ensuring compliance with regulatory requirements and mitigating legal risks associated with drug development and commercialization. This executive leadership role is critical for navigating the complex legal and regulatory landscape of the biopharmaceutical industry, particularly concerning intellectual property, corporate governance, and clinical trial protocols. Shannon Kelley advises on matters related to the company's therapeutic candidates, including MGL-3196, and supports strategic transactions and partnerships. The Chief Legal Officer's responsibilities encompass managing litigation, contracts, and ensuring adherence to global compliance standards. By safeguarding the company's legal interests, Kelley enables Madrigal Pharmaceuticals to pursue its mission of treating cardiovascular, metabolic, and liver diseases with confidence and integrity.

David Soergel, the Executive Vice President & Chief Medical Officer at Madrigal Pharmaceuticals, leads the company's clinical development strategy and execution. Soergel directs the design, implementation, and oversight of clinical trials for the company's therapeutic candidates, including the lead asset MGL-3196. This executive leadership role is paramount in advancing treatments for cardiovascular, metabolic, and liver diseases, ensuring scientific rigor and patient safety throughout the development process. David Soergel guides the interpretation of clinical data and collaborates with regulatory authorities to facilitate drug approval pathways. The Chief Medical Officer's responsibilities include managing the medical affairs team, engaging with key opinion leaders, and ensuring that clinical programs align with the company's overall strategic objectives. Soergel's medical expertise and strategic vision are essential for driving Madrigal Pharmaceuticals' pipeline forward and achieving its goal of bringing innovative therapies to patients.